1. Home
  2. ORBS vs IMRX Comparison

ORBS vs IMRX Comparison

Compare ORBS & IMRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Eightco Holdings Inc.

ORBS

Eightco Holdings Inc.

HOLD

Current Price

$0.73

Market Cap

262.0M

Sector

N/A

ML Signal

HOLD

IMRX

Immuneering Corporation

HOLD

Current Price

$5.09

Market Cap

288.6M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ORBS
IMRX
Founded
1966
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
262.0M
288.6M
IPO Year
2022
2021

Fundamental Metrics

Financial Performance
Metric
ORBS
IMRX
Price
$0.73
$5.09
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$17.20
AVG Volume (30 Days)
11.9M
748.7K
Earning Date
04-14-2026
05-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
37.75
EPS
N/A
N/A
Revenue
$31,820,779.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.57
$3.25
52 Week High
$15.96
$10.08

Technical Indicators

Market Signals
Indicator
ORBS
IMRX
Relative Strength Index (RSI) 55.04 63.56
Support Level $0.58 $4.82
Resistance Level $0.96 $5.27
Average True Range (ATR) 0.05 0.24
MACD 0.02 0.11
Stochastic Oscillator 80.21 88.21

Price Performance

Historical Comparison
ORBS
IMRX

About ORBS Eightco Holdings Inc.

Eightco Holdings Inc operates in Forever 8 Inventory Cash Flow Solution. The company is a dynamic technology-focused company committed to driving growth and innovation through strategic acquisitions and management. Forever 8 focuses on purchasing inventory for e-commerce retailers and is part of its Inventory Solution Business. Corrugated Packaging Business manufactured and sold custom packaging for a wide products and through packaging helps customers generate brand awareness and promote brand image. Generate the substantial majority of revenues from inventory financing and inventory management services.

About IMRX Immuneering Corporation

Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to pharmaceutical and biotechnology companies.

Share on Social Networks: